Skip to main content

Table 4 Reported PHKA2 mutations in Asian patients with glycogen storage disease (GSD) type IX

From: PHKA2 mutation spectrum in Korean patients with glycogen storage disease type IX: prevalence of deletion mutations

Ethnicity

Exon number

Nucleotide change

Amino acid change

Mutation type

Reference

Point mutation

    

Chinese

2

c.136delG

p.Asp46Ilefs*37

Frameshift

[31]

Japanese

4

c.346 T > G

p.Tyr116Asp

Missense

[32]

Japanese

6

c.578G > T

p.Gly193Val

Missense

[32]

Japanese

9

c.883C > T

p.Arg295Cys

Missense

[25]

Korean

9

c.884G > Aa

p.Arg295His

Missense

[8], This study

Japanese

15

c.1489C > T

p.Arg497*

Nonsense

[25]

Japanese

16

c.1697A > T

p.Ile566Asn

Missense

[33]

Japanese

32

c.3505C > T

p.Gln1169*

Nonsense

[25]

Japanese, Chineseb

33

c.3614C > T

p.Pro1205Leu

Missense

[22, 24, 32, 34]

Splicing mutation

    

Japanese

2

c.79-1G > T

Exon 2 skipping

Splicing

[25]

Korean

IVS5

c.537 + 5G > A

?c

Splicing

[6], This study

Japanese

25

c.2675A > G

Exon 25 skipping

Splicing

[32]

Chinese

30

c.3112-1G > A

Exon 30 skipping

Splicing

[31]

Deletion mutation

    

Korean

30

c.3210_3212delGAG

p.Arg1072del

Small deletion

[18, 19], This study

Korean

8

 

Exon 8 deletion

Gross deletion

[13], This study

Korean

18–33

 

Exon 18–33 deletions

Gross deletion

This study

Japanese

20–26

 

Exon 20–26 deletions

Gross deletion

[29]

Korean

27–33

 

Exon 27–33 deletions

Gross deletion

[6], This study

  1. aThis mutation has been reported previously in two patients with GSD IX and is predicted to affect protein function by in silico analyses (SIFT and PolyPhen-2) and to affect splicing, potentially through activation of an exonic cryptic donor site, by both Human Splice Finder software and by a machine-learning technique that scores how strongly genetic variants affect RNA splicing [27]
  2. bThis mutation has been reported as a founder mutation in the Dutch population
  3. cAlthough in vitro analysis for the splicing effect of c.537 + 5G > A was not performed, in vivo results confirming phosphorylase b kinase deficiency have been reported to constitute a pathogenic mutation in a patient with GSD IX in previous literature. This mutation was predicted to affect splicing, potentially through alteration of the wild-type donor site